Literature DB >> 18094092

Airway smooth muscle cell as an inflammatory cell: lessons learned from interferon signaling pathways.

Omar Tliba1, Yassine Amrani.   

Abstract

The present article will describe the potential role of airway smooth muscle (ASM) in mediating both deleterious/beneficial effects of interferons (IFNs) in asthma. First described as beneficial in treating the main features of asthma, the interplay between IFNs and ASM could explain their deleterious actions recently described in a number of different studies. Through multiple mechanisms, including the suppression of steroid action, the synergistic pro-inflammatory actions when combined with other cytokines, and the modulation of calcium metabolism, IFNs are now seen as critical mediators in the pathogenesis of asthma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18094092      PMCID: PMC2645295          DOI: 10.1513/pats.200705-060VS

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  86 in total

1.  Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation.

Authors:  J L Cheshire; A S Baldwin
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

Review 2.  Airway smooth muscle as a target of glucocorticoid action in the treatment of asthma.

Authors:  S J Hirst; T H Lee
Journal:  Am J Respir Crit Care Med       Date:  1998-11       Impact factor: 21.405

3.  The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function.

Authors:  R H Oakley; M Sar; J A Cidlowski
Journal:  J Biol Chem       Date:  1996-04-19       Impact factor: 5.157

Review 4.  STATs and gene regulation.

Authors:  J E Darnell
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

5.  Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB.

Authors:  Y Ohmori; R D Schreiber; T A Hamilton
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

6.  Induction of Jak/STAT signaling by activation of the type 1 TNF receptor.

Authors:  D Guo; J D Dunbar; C H Yang; L M Pfeffer; D B Donner
Journal:  J Immunol       Date:  1998-03-15       Impact factor: 5.422

7.  Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids.

Authors:  M John; S J Hirst; P J Jose; A Robichaud; N Berkman; C Witt; C H Twort; P J Barnes; K F Chung
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

Review 8.  Transcription factors in interferon signaling.

Authors:  M David
Journal:  Pharmacol Ther       Date:  1995-02       Impact factor: 12.310

9.  Intercellular adhesion molecule 1 (ICAM-1) is synergistically activated by TNF-alpha and IFN-gamma responsive sites.

Authors:  A Jahnke; J P Johnson
Journal:  Immunobiology       Date:  1995-07       Impact factor: 3.144

10.  Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta.

Authors:  D Y Leung; Q Hamid; A Vottero; S J Szefler; W Surs; E Minshall; G P Chrousos; D J Klemm
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

View more
  11 in total

1.  Interferons modulate mitogen-induced protein synthesis in airway smooth muscle.

Authors:  Elena A Goncharova; Poay N Lim; Amelia Chisolm; Homer W Fogle; Jerome H Taylor; Dmitry A Goncharov; Andrew Eszterhas; Reynold A Panettieri; Vera P Krymskaya
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-09       Impact factor: 5.464

2.  Effect of the plant derivative Compound A on the production of corticosteroid-resistant chemokines in airway smooth muscle cells.

Authors:  Adelina Gavrila; Latifa Chachi; Omar Tliba; Christopher Brightling; Yassine Amrani
Journal:  Am J Respir Cell Mol Biol       Date:  2015-11       Impact factor: 6.914

3.  Caveolin-1 in cytokine-induced enhancement of intracellular Ca(2+) in human airway smooth muscle.

Authors:  Venkatachalem Sathish; Amard J Abcejo; Sarah Kay VanOosten; Michael A Thompson; Y S Prakash; Christina M Pabelick
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-29       Impact factor: 5.464

4.  Functional KCa3.1 channels regulate steroid insensitivity in bronchial smooth muscle cells.

Authors:  Peter Bradding; Yassine Amrani; Latifa Chachi; Aarti Shikotra; S Mark Duffy; Omar Tliba; Christopher Brightling
Journal:  J Immunol       Date:  2013-07-31       Impact factor: 5.422

Review 5.  Transcriptional regulation of cytokine function in airway smooth muscle cells.

Authors:  Deborah Clarke; Gautam Damera; Maria B Sukkar; Omar Tliba
Journal:  Pulm Pharmacol Ther       Date:  2009-04-22       Impact factor: 3.410

Review 6.  Airway smooth muscle as an immunomodulatory cell.

Authors:  Gautam Damera; Omar Tliba; Reynold A Panettieri
Journal:  Pulm Pharmacol Ther       Date:  2008-12-24       Impact factor: 3.410

7.  T-bet is induced by interferon-γ to mediate chemokine secretion and migration in human airway smooth muscle cells.

Authors:  Cherie A Singer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-01-14       Impact factor: 5.464

8.  Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells.

Authors:  A Banerjee; G Damera; R Bhandare; S Gu; Ys Lopez-Boado; Ra Panettieri; O Tliba
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

Review 9.  Refractory asthma: mechanisms, targets, and therapy.

Authors:  J L Trevor; J S Deshane
Journal:  Allergy       Date:  2014-04-29       Impact factor: 13.146

10.  Novel Comprehensive Bioinformatics Approaches to Determine the Molecular Genetic Susceptibility Profile of Moderate and Severe Asthma.

Authors:  Hatem Zayed
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.